SGS Société Générale de Surveillance SA

Company Snapshot

Founded: 1878
Entity Type: Public
Employees: 102,804
Region: Europe/Africa/Middle East
Revenue: $8,379.4 Millions
Revenue Year: 2025
Headquarter: Baar, Switzerland
Key Geographics: Americas, Asia-Pacific, Europe, Middle East and Africa
Corporate Address: 1 Place des Alpes P.O. Box 2152, 1211 Geneva, Switzerland Tel: +41-22-739-91-11 Web: www.sgs.com

Company Overview

SGS Société Générale de Surveillance SA forms part of SGS, a global inspection, testing, and certification company headquartered in Geneva, Switzerland. It provides analytical testing, quality assessment, and compliance services that support clients in regulated industries, including pharmaceuticals, chemicals, consumer goods, and environmental monitoring. Its activities include laboratory testing, auditing, verification, and scientific analysis, which help organizations meet safety, regulatory, and performance requirements.

SGS Société Générale de Surveillance SA, also known as SGS General Surveillance Co. SA, offers a range of laboratory services, including analytical chemistry, cell-based screening, genotoxicity assessments, and method development for regulatory submissions. The services also support early hazard identification, mechanism-of-action studies, and compliance with international testing guidelines. By combining laboratory infrastructure with scientific expertise, it enables customers to generate data for safety evaluation across pharmaceuticals, industrial chemicals, agrochemicals, and consumer-product applications.

Financial Highlights (FY 2025)

Net Revenue: ***
Total Current Liabilities: ***
Total Current Assets: ***
Operating Income: ***

This information is available for BCC Research members only.

SGS Société Générale de Surveillance SA In Reports

In Vitro Toxicity Testing: Technologies and Global Markets

BCC Research detailed report on in vitro toxicity testing market includes global revenue ($ Million) for base year data 2024 and estimated data for the forecast period 2025 through 2030.

Validation, Calibration, and Standardization in the Life Sciences Market

According to BCC Research detailed report on Validation Calibration and Standardization in the Life Sciences Market revenue ($ Million) for the base year data of 2024 and estimated data for the forecast period 2025...

Global EV Battery Testing Market

Our Research report provides an overview of the EV battery testing market current, and future market scenarios 2024 is considered a base year, and 2025 is an estimated year market values are forecasted until 2030.

Company's Business Segments

  • Testing & Inspection : Testing products ensures they meet health, safety and regulatory standards. Inspection controls quantity and quality to help our customers meet regulatory requirements.
  • Certification : Certification provides assurance that products, processes, systems or services meet standards and regulations.

Applications/End User Industries

  • Consumer Products
  • Retail
  • Cosmetic and Personal Care
  • Cybersecurity
  • Technology
  • Buildings and Infrastructure
  • Power
  • Utilities
  • Agriculture and Forestry
  • Food
  • Environment
  • Health & Safety
  • Industrial Manufacturing & Processing
  • Mining
  • Chemicals
  • Oil and Gas
  • Transportation
  • Medtech
AI Sentiment